Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 373 - 384 items out of 534 results
Press release
National Lung Matrix Trial (NLMT): First Results from an Umbrella Phase II Trial in Advanced NonSmall Cell Lung Cancer (NSCLC)
Press release
Registrational Data from LIBRETTO-001 Trial Demonstrate Compelling and Durable Activity of Selpercatinib (LOXO-292) in RET Fusion-Positive Lung Cance
Press release
Lung cancer screening model favored in Europe detects more cancers than one preferred in the United States
Press release
Scottish Study Demonstrates that Autoantibody Test Followed By CT Imaging May Reduce Lung Cancer Mortality
Press release
Durvalumab combined with chemotherapy improves overall survival in patients with extensive lung stage cancer; First-line treatment reduces mortality risk by 27 percent
Press release
BioMILD Trial Demonstrates Lung Cancer Screening Using MicroRNA Blood Test Enhances Prevention Effort
Press release
KEYNOTE 189: Tumor Mutational Burden Not Significantly Associated with Efficacy of Pembrolizumab
Press release
Phase 1 Study Shows Novel KRAS Inhibitor Well Tolerated by Patients with Adenocarcinoma and NonSmall Cell Lung Cancer
Press release
New KEYNOTE 021 Data Shows No Association with Tumor Mutational Burden
Press release
Nivolumab combined with ipilimumab safe as first-line therapy for lung cancer patients with comorbid diseases
Press release
Tobacco Cessation After Cancer Diagnosis: Declaration from the IASLC
Press release
Lung Ambition Alliance unveils new initiatives to address lung cancer survival at the World Conference on Lung Cancer
Pagination
First
First page
‹
Previous page
…
28
29
30
31
32
33
34
35
36
…
›
Next page
Last
Last page